96 related articles for article (PubMed ID: 4208032)
1. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
[No Abstract] [Full Text] [Related]
2. A double blind study of Visken LB-46, in the treatment of angina pectoris.
Nair DV
Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
[No Abstract] [Full Text] [Related]
3. Long-term propranolol therapy in essential circulatory hyperkinesis.
Török E; Bajkay G; Gulyás A; Istvánffy M; Matos L
Int J Clin Pharmacol; 1972 Nov; 6(4):364-74. PubMed ID: 4629827
[No Abstract] [Full Text] [Related]
4. Visken (LB-46) a double blind cross-over study in cardiac arrhythmias.
Damany SJ; Bhatt GR
Indian Heart J; 1972 Jun; 24():Suppl 1:211-2. PubMed ID: 4581429
[No Abstract] [Full Text] [Related]
5. A double blind drug trial of LB-46 (visken) in angina pectoris.
Sainani GS; Mukherjee AK
Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
[No Abstract] [Full Text] [Related]
6. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
Waal-Manning HJ; Simpson FO
N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
[No Abstract] [Full Text] [Related]
7. Pindolol (Visken) and angina pectoris: a double blind multicentre trial.
Thorpe P
N Z Med J; 1972 Sep; 76(484):171-3. PubMed ID: 4564998
[No Abstract] [Full Text] [Related]
8. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
Persson I; Ulrich J
Eur J Clin Pharmacol; 1973 Dec; 6(4):217-9. PubMed ID: 4591149
[No Abstract] [Full Text] [Related]
9. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
Srivastava BN; Jain PC; Vyas GP
Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
[No Abstract] [Full Text] [Related]
10. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
Bloch A; Horvat L
Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
[No Abstract] [Full Text] [Related]
11. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Bjerle P; Jacobsson KA
Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
[No Abstract] [Full Text] [Related]
12. [Pindolol in arterial hypertension. A double-blind study (author's transl)].
Basso B; Roman O
Rev Med Chil; 1976 Mar; 104(3):143-7. PubMed ID: 781772
[No Abstract] [Full Text] [Related]
13. [Beta blocker treatment in alcohol withdrawal. A double-blind test with pindolol (Viskén)/placebo].
Digranes O
Tidsskr Nor Laegeforen; 1976 Feb; 96(4):226-8. PubMed ID: 766297
[No Abstract] [Full Text] [Related]
14. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
Persson I; Ulrich J
Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
[No Abstract] [Full Text] [Related]
15. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
Merté HJ; Stryz JR; Mertz M
Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
[TBL] [Abstract][Full Text] [Related]
16. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
Rosenfeld JB; Traub YM; Cohen L
Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
[No Abstract] [Full Text] [Related]
17. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
Wyrzykowski B; Suchecka-Rachoń K
Kardiol Pol; 1986; 29(4):285-91. PubMed ID: 3537436
[No Abstract] [Full Text] [Related]
18. Pindolol in hypertension: a double-blind trial.
Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
[No Abstract] [Full Text] [Related]
19. [Contraction and output capacity of the heart with coronary disease during beta adrenolysis using LB 46 (visken)].
Limbourg P; Just H
Z Kreislaufforsch; 1972 Sep; 61(9):789-801. PubMed ID: 4637850
[No Abstract] [Full Text] [Related]
20. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
Schaffalitzky de Muckadel ; Gyntelberg F
Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
